Spartan Medical Announces Partnership with Altapure to Provide Fully Integrated High-Level Disinfectant System

October 14, 2020

Spartan Medical Inc., a Service-Disabled Veteran-Owned Small Business founded in 2008, has announced a partnership with Altapure, LLC, a manufacturer of innovative products, to bring its AP-4 High-level Disinfection-System (HLDS) to the national market.

Spartan Medical notes this critically needed, advanced-ultrasonic-technology ensures that all healthcare and long-term care facilities, schools, universities, cruise lines, etc, can provide the cleanest/safest environment to our fellow Americans.

Spartan’s team passionately believes now is the time to provide the AP–4 Medical HLD System, Altapure’s first fully integrated High-Level Disinfection system, to reproducibly eliminate all bacteria, spores and viruses in a treated space. The AP–4 is a single mobile unit platform, containing a combined submicron aerosol output device, and environmental air re-processor system with data feedback.

Altapure is the market leader in total surface disinfection with an automated process, that is safe for electronics, and other complex medical equipment; the process’s agent is organic, biodegradable, food safe, and leaves zero residue. Altapure’s PAA agent is an EPA registered cold sterilant, bactericide, fungicide, virucide and sporicide; this unique technology is backed by real science, and is unmatched by anything available to date. In short, there has not yet been a pathogen that can survive the disinfection cycle, making the implementation of this state-of-the-art solution paramount during COVID-19 and beyond.

As Americans continue to press forward, and navigate the precarious environment that has become our new normal, it is imperative that we do everything in our power to mitigate all unnecessary risks. The Altapure system is easily operated by 1 person, and many facilities have 1 person running 2-3 machines at a time. The AP-4 is mobile, fast, easy to use, safe, and most of all, effective, exceeding the EPA’s performance disinfection definition. Further, in collaboration with NASA, Altapure has shown efficacy in the sterilization of PPE with the ‘peracetic acid technology.

Spartan Medical’s Founder and President, Vince Proffitt, is a 1999 Air Force Academy Graduate who served 5-years active duty as a USAF Intelligence Officer. Mr. Proffitt recently stated, “It’s our Spartan team’s distinct honor and privilege to partner with Altapure, and lead the way in the fight against COVID-19, and beyond. Together with Altapure, our joint mission is to ensure our customers are armed with every weapon commercially available to keep our brothers and sisters as safe as possible, while quickly maximizing innovation and safety to take the fight of our generation to COVID-19!”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.